PR
PHVS icon

PSP Research’s Pharvaris PHVS Stock Holding History

PSP Research’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Sell
15,000
-5,000
-25% -$151K 0.28% 15
2026
Q1 		$565K Sell
20,000
-511
-2% -$13.6K 0.4% 7
2025
Q4 		$569K Buy
+20,511
New +$494K 0.5% 5

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

PSP Research's PHVS Position: Q2 2026 in Review

PSP Research reduced its Pharvaris (PHVS) stake by 25% in Q2 2026, selling an estimated $151K and leaving 15,000 shares worth $519K. The position accounts for 0.28% of the portfolio, ranked #15.

PSP Research first reported a position in PHVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $569K in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • PSP Research held 15,000 shares of Pharvaris worth $519K as of Q2 2026.
  • PSP Research sold 5,000 Pharvaris shares in Q2 2026, an estimated $151K.
  • Pharvaris made up 0.28% of PSP Research's portfolio in Q2 2026, its #15 holding.
  • PSP Research first reported a position in Pharvaris in Q4 2025 and has held it in 3 quarters since.
  • PSP Research's Pharvaris position peaked at $569K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.